{"id":"fluad-and-prevenar13","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain, erythema, or swelling"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Fluad is an inactivated influenza vaccine that contains viral antigens to induce antibody production against seasonal influenza strains. Prevenar13 is a 13-valent pneumococcal conjugate vaccine that conjugates pneumococcal polysaccharide antigens to a protein carrier to enhance immune response against 13 serotypes of Streptococcus pneumoniae. Together, they provide protection against both influenza and invasive pneumococcal disease.","oneSentence":"This is a combination of two vaccines: Fluad (inactivated influenza vaccine) and Prevenar13 (pneumococcal conjugate vaccine) that stimulate immune responses against influenza and pneumococcal pathogens.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:46:34.141Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of seasonal influenza"},{"name":"Prevention of invasive pneumococcal disease caused by 13 serotypes of Streptococcus pneumoniae"}]},"trialDetails":[{"nctId":"NCT02215863","phase":"PHASE4","title":"Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years","status":"COMPLETED","sponsor":"Korea University Guro Hospital","startDate":"2014-09","conditions":"Influenza, Streptococcus Pneumoniae","enrollment":1195}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Fluad and Prevenar13","genericName":"Fluad and Prevenar13","companyName":"Korea University Guro Hospital","companyId":"korea-university-guro-hospital","modality":"Biologic","firstApprovalDate":"","aiSummary":"This is a combination of two vaccines: Fluad (inactivated influenza vaccine) and Prevenar13 (pneumococcal conjugate vaccine) that stimulate immune responses against influenza and pneumococcal pathogens. Used for Prevention of seasonal influenza, Prevention of invasive pneumococcal disease caused by 13 serotypes of Streptococcus pneumoniae.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}